Apical Ballooning Syndrome

download Apical Ballooning Syndrome

of 33

Transcript of Apical Ballooning Syndrome

  • 8/4/2019 Apical Ballooning Syndrome

    1/33

    Transient Left VentricularTransient Left Ventricular

    Apical Ballooning SyndromeApical Ballooning Syndrome

    TakoTako--Tsubo / AmpullaTsubo / Ampulla

    CardiomyopathyCardiomyopathy

  • 8/4/2019 Apical Ballooning Syndrome

    2/33

    CharacteristicsCharacteristics First described in 1991 by Sato & Dote et al in Japanese literatureFirst described in 1991 by Sato & Dote et al in Japanese literature

    AnginaAngina

    ST segment elevation / diffuse T wave inversion / abnormal Q wavesST segment elevation / diffuse T wave inversion / abnormal Q waves

    RWMA in lower anterior wall and apexRWMA in lower anterior wall and apex

    Myocardial enzyme release (mild to mod.)Myocardial enzyme release (mild to mod.)

    Hemodynamically insignificant stenosis on CAGHemodynamically insignificant stenosis on CAG

    Psychological / physical stress within minutes to hours of onset ofPsychological / physical stress within minutes to hours of onset ofsymptomssymptoms

    Hemodynamic compromise, cardiac arrestHemodynamic compromise, cardiac arrest

    Rapid resolution of RWMA & normalization of EF in 7Rapid resolution of RWMA & normalization of EF in 7--30 days30 days

  • 8/4/2019 Apical Ballooning Syndrome

    3/33

    Systematic Review of 7 case seriesSystematic Review of 7 case seriesAnn Intern Med 2004

    Demographics and Presenting Symptoms

    82% to 100% were women

    Mean age was 62 to 75 years

    Presenting symptom chest pain (33% to 71%)

    Dyspnea & rarely syncope

  • 8/4/2019 Apical Ballooning Syndrome

    4/33

    ECG findings on admission

    ST-segment elevation (46% to 100%)

    Mostly precordial leads and more marked in V4-V6

    Isolated inferior or lateral ST elevation unusual

    New LBBB and RBBB

    Almost all patients developed T-wave inversions usually present inmost leads.

    New pathologic Q waves (6% to 31%)

    The corrected QT interval (mean 0.45 s to 0.50 s)

    Systematic ReviewSystematic Review

  • 8/4/2019 Apical Ballooning Syndrome

    5/33

    Cardiac Enzyme and Biomarker Release

    Most patients had a modest increase in cardiac enzyme levels.

    56% incidence of increase in creatine kinase

    100% incidence of increase in cardiac troponin

    Peak levels are often those drawn at the time of initial

    presentation

    Do not follow the kinetics observed with conventional MI.

    Systematic ReviewSystematic Review

  • 8/4/2019 Apical Ballooning Syndrome

    6/33

    Angiographic Data and LV Function

    No angiographically detectable lesion(25% to 100%)

    Nonobstructive coronary disease (0% to 75%)

    None of the patients had epicardial stenosis greater than 50%

    Mean LVEF at presentation 0.39 to 0.49

    LVEF improved rapidly over a period of days to weeks to mean0.60 to 0.76

    Apical and mid-ventricular RWMA completely resolved in mostpatients

    Systematic ReviewSystematic Review

  • 8/4/2019 Apical Ballooning Syndrome

    7/33

    Endothelial Function and Coronary Microcirculation

    Either spontaneous or provocable multivessel epicardial spasmwas present in 0% to 43%

    Coronary flow reserve (coronary microvascular function)showed conflicting results

    Abnormal TIMI frame counts in all 3 major epicardial coronary

    arteries during the acute phase of the syndrome

    Systematic ReviewSystematic Review

  • 8/4/2019 Apical Ballooning Syndrome

    8/33

    Clinical Complications and Outcome n-hospital mortality rates - 0% to 8%

    Significant LV failure during the acute phase in 3% to 46%

    A transient, dynamic intraventricular pressure gradient due toobstruction in the LV cavity in 13% to 18% with MR

    AV block, sinus bradycardia, paroxysmal atrial fibrillation, VT and Vfib

    Isolated cases of LV mural thrombus formation

    1 case of LV freewall rupture occurred 3 days after presentation

    Cardiogenic shock

    Death

    Systematic ReviewSystematic Review

  • 8/4/2019 Apical Ballooning Syndrome

    9/33

    Preceding Stressors, Incidence, and Recurrence

    Most patients presented immediately after an episode of acute

    emotional (14% to 38%) or physiologic (17% to 77%)

    In 1 series, this syndrome represented 2.2% of ST elevation

    ACS presenting to a referral hospital during 2002 and 2003

    A separate series, this syndrome was diagnosed in 1.5% of

    patients who had presented with an Qwave ACS

    Recurrence of the syndrome seems to be rare (0% to 8%)

    Systematic ReviewSystematic Review

  • 8/4/2019 Apical Ballooning Syndrome

    10/33

    Possible triggering factorsPossible triggering factors

    Systemic disordersSystemic disorders

    CVACVA

    epileptic attacksepileptic attacks

    exacerbation of bronchialexacerbation of bronchialasthmaasthma

    acute abdomenacute abdomen

    noncardiac surgery/procedurenoncardiac surgery/procedure

    PnuemothoraxPnuemothorax

    Emotional/physical problemsEmotional/physical problems

    death/funeral of family memberdeath/funeral of family member

    Surprise party / reunionSurprise party / reunion

    fear of procedurefear of procedure

    public speakingpublic speaking

    court appearancecourt appearance

    tragic newstragic news

    sudden accidentssudden accidentsinexperienced exerciseinexperienced exercise

    quarrelingquarreling

    excessive alcohol consumptionexcessive alcohol consumption

    vigorous excitationvigorous excitation

  • 8/4/2019 Apical Ballooning Syndrome

    11/33

    MechanismMechanism Several mechanisms have been proposed

    Catecholamines mediated myocardial stunning

    neurogenically mediated

    direct metabolic injury

    multivessel epicardial spasm

    microvascular coronary spasm/dysfunction

    Abnormal LAD anatomy

    Intraventricular gradient

    Genetic

  • 8/4/2019 Apical Ballooning Syndrome

    12/33

    Neurogenic

    Acute mental stress, a time of enhanced sympathetic outflow

    The distribution of apical WMA is similar to the distribution reportedwith catecholamine-induced cardiomyopathy (pheochromocytoma,

    GBS, SAH)

    Increased adrenergic receptor density and responsiveness in theapical segments

    In a rat model the RWMA could not be reproduced after pretreatmentwith adrenoreceptor antagonist

    Measurements of circulating catecholamine levels have showninconsistent results suggesting that activation of cardiacadrenoceptors maybe the primary cause.

  • 8/4/2019 Apical Ballooning Syndrome

    13/33

    Direct metabolic injury

    Elevated catecholamine level decrease the viability of myocytesthrough cAMPmediated calcium overload and formation of freeradicals causing necrosis

    Transient exposure to excessive catecholamines, may resultin stunning with cellular metabolic abnormalities rather than necrosis

    Pulmonary sympathetic stimulation increases the pore size in thepulmonary capillaries, leading to alveolar transudation

    Studies have demonstrated a reduction of the fatty acid metabolismand mitochondrial function in the apical myocardium by usingisotopes, suggesting direct myocardial toxicity

  • 8/4/2019 Apical Ballooning Syndrome

    14/33

    Coronary spasmCoronary spasm

    In an angiographic studies,

    spontaneous spasm seen very occasionally

    70 % had coronary spasm (single/multivessel) in response to

    provocative maneuvers (ergonovine or acetylcholine)

    ST elevation was common at presentation

    Multivessel coronary vasospasm (which could probably produce

    diffuse wall-motion abnormalities), was found in 18% patients testedacross series

    Transient multivessel epicardial spasm may be responsible for some

    cases of the syndrome

  • 8/4/2019 Apical Ballooning Syndrome

    15/33

    Microcirculatory spasm/dysfunctionMicrocirculatory spasm/dysfunction

    Coronary microvascular function has been shown to be diffuselyabnormal when assessed using CFR and TIMI frame counts

    IC nicorandil during the acute phase acutely reduced the extent

    of ST elevation

    Regional defects on cardiac imaging suggests sympatheticallymediated microcirculatory dysfunction.

    ? primary mechanism or secondary phenomenon

  • 8/4/2019 Apical Ballooning Syndrome

    16/33

    Abnormal LAD anatomyAbnormal LAD anatomy

    In a series of 5 tako-tsubo patients,the LAD had a long course around the LV apex, supplying an

    extensive portion of the diaphragmatic LV aspect

    Transient coronary artery occlusion/reperfusion episodes may lead tostunning and akinesia also the minimal release of biomarkers withtotal recovery of cardiac function

    Pathogenesis of this disorder could be similar to that of AMI:

    coronary atherosclerotic plaque complicated by thrombotic occlusion

    Evidence supporting the hypothesis is weak and hardly explainscharacteristics of this syndrome

  • 8/4/2019 Apical Ballooning Syndrome

    17/33

    ntraventricular gradientIntraventricular gradient

    Clinical and hemodynamic situation improved when the gradientdisappeared and in some cardiogenic shock persisted until thedynamic obstruction was present

    Dynamic obstruction raise intraventricular pressures in the distal

    chamber and reduce myocardial perfusion, leading to ischemia anddyskinesia

    Exposure to an exogenous catecholamine (dobutamine), can provokedynamic LVOT obstruction even in normal hearts

    Some women might have a geometric predisposition (sigmoidseptum, narrow LVOT, reduced LV volume) to the development ofdynamic subaortic obstruction that would only manifest with intenseadrenergic stimulation

  • 8/4/2019 Apical Ballooning Syndrome

    18/33

    Proposed pathophysiologicalmechanism of TLVABS

  • 8/4/2019 Apical Ballooning Syndrome

    19/33

    Female PreponderanceFemale Preponderance

    Sex hormones exert important influences on the sympatheticneurohormonal axis as well as on coronary vasoreactivity.

    Women are more vulnerable to sympathetically mediated myocardialstunning (transient LV dysfunction after SAH)

    Explanation - alterations of endothelial function and microcirculatoryvasomotor reactivity due to reduced estrogen levels

    Estradiol supplementation attenuates emotional stressinducedchanges in LV function in ovariectomized female rats.

  • 8/4/2019 Apical Ballooning Syndrome

    20/33

    PATHOLOGICAL FINDINGS

    Interstitial fibrosis was a common finding and no significant

    inflammation necrosis during the acute phase

    Later myocytolysis, with cell infiltrates including mononuclear

    cells and increase of loose connective tissue.

    The histologic findings in this heart syndrome, were similar toThe histologic findings in this heart syndrome, were similar to

    those observed in catecholaminethose observed in catecholamine--induced cardiomyopathyinduced cardiomyopathy

    There was no evidence of acute myocarditis in any series.

  • 8/4/2019 Apical Ballooning Syndrome

    21/33

    Proposed Mayo Criteria for the ClinicalDiagnosis

    1. Transient akinesis or dyskinesis of the left ventricular apical and mid-ventricular segments with regional wall-motion abnormalities extendingbeyond a single epicardial vascular distribution

    2. Absence of obstructive coronary disease or angiographic evidence of acute

    plaque rupture

    3. New electrocardiographic abnormalities (either ST-segment elevation or Twave inversion)

    4. Absence ofRecent significant head traumaIntracranial bleedingPheochromocytomaObstructive epicardial coronary artery diseaseMyocarditis

    Hypertrophic cardiomyopathy * All 4 criteria must be met

  • 8/4/2019 Apical Ballooning Syndrome

    22/33

    Diagnosis of TLVABS Prior conditions (both obligatory):

    Evidence of transient apical dysfunction of LV with a typical shape inthe systole, diagnosed by angio, echo, isotopes, or cardiac MRI. Normalventricular mobility returns in 2-3 weeks

    Absence of other conditions associated with transient regional systolicdysfunction of the LV: SAH, pheochromocytoma, cardiac ischemia, toxicsubstances (cocaine), myocarditis, etc.

    Diagnostic CriteriaMajorcriteria

    Early coronary angiography (first24 h) withoutanatomical lesions

    Minorcriteria1. Early coronary angiography with non-significant lesions2. Late coronary angiography(2 to7 days) withoutsignificant lesions3. Disordertriggered by physical oremotional stress4. Typical ECG changes ST segmentelevation in acute phase, Q waves

    thatdisappearafteracute phase, T inversion prominentin V1-V6

    and prolongation of QTc5. Woman aged >50 years

  • 8/4/2019 Apical Ballooning Syndrome

    23/33

    ManagementManagement Beta-blockers

    ACEI (in patients without an intracavitary gradient)AspirinIV diuretics

    Pts with hypotension must be evaluated for a dynamic intraventricularpressure gradient in the LV cavity and LVOT which is managed by

    beta-blockers,phenylephrinefluid resuscitation

    Beta-blockers and phenylephrine are not recommended in documentedepicardial coronary vasospasm (diltiazem or verapamil)

    Short-term anticoagulation if significant LV dysfunction and continued untilLV function has improved

    Monitoring for atrial and ventricular arrhythmias, heart failure, andmechanical complications.

  • 8/4/2019 Apical Ballooning Syndrome

    24/33

    69-year-old womanacute chest pain

    CPKMB was elevatedurgent CAG - normal coronaries

    LV angio-apical ballooning insystole

    LVEF of 33% & severe MRMidcavity gradient of 25

    mmHg

    Supportive therapyClinical recovery within 1 weekLV function normal at 40 days

  • 8/4/2019 Apical Ballooning Syndrome

    25/33

    8080--yearyear

    --old woman withold woman withhypertensionhypertension

    33--hour history of dyspnoea andhour history of dyspnoea andprecordial discomfortprecordial discomfort

    trop T, CPK and CPKtrop T, CPK and CPK--MB wereMB werenormalnormal

    patient developed haemodynamicpatient developed haemodynamicinstability, cardiac cath was doneinstability, cardiac cath was done

    The patients condition improvedThe patients condition improvedafterafter an IABP was placedan IABP was placed

    Echo 3Echo 3 weeks later showedweeks later showednormal LV size and function.normal LV size and function.

  • 8/4/2019 Apical Ballooning Syndrome

    26/33

    78-year-old woman withhypertension

    acute epigastric pain since 12hours

    melena and Hb of8g/L.

    After transfusion of 2 units ofpacked RBCs, the symptomsdisappeared and the ECGevidenced extensive anteriorsubepicardial ischemia.

    The trop I was 8.5 ng/mL.

    Echo showed anteroapicalakinesia and dynamicsubaortic obstruction with apeak gradient of 42 mm Hg

    Cath performed 5 days latershowed normal coronariesand apical ballooning

    She has remainedasymptomatic after 15 monthsof follow-up, with normalizedECG and LV wall motion

  • 8/4/2019 Apical Ballooning Syndrome

    27/33

    64 year old woman

    No coronary risk factors

    continuous atypical chest pain-2d

    Maximal CPK and trop I valueswere 159 U/l (normal 0170) and7.4 ng/ml (00.1)

    CAG-normal coronaries

    LV angio - apical ballooning, apicalthrombus. LVEF 40%. Confirmedwith TTE (IV gradient 75mmHg)

    Pathologic Q waves developedfrom V1-V3

    discharged under anticoagulants

    3 months later T in V3V6TTE - normal LVwall motion, LVEF62%, complete resolution of theapical thrombus and IV pressuregradient

    Apical thrombus in TLVABSApical thrombus in TLVABS

  • 8/4/2019 Apical Ballooning Syndrome

    28/33

    Indian Heart JournalIndian Heart Journal

    5 cases (all females) aged 225 cases (all females) aged 2240 years40 years

    Presenting with severe transient LV dysfunction, and cardiogenicPresenting with severe transient LV dysfunction, and cardiogenic

    shock following surgery (cesarean section 2, laparoscopicshock following surgery (cesarean section 2, laparoscopic

    cholecystectomy 3)cholecystectomy 3)

    All the patients had ECG changes in multiple leads, suggestive ofAll the patients had ECG changes in multiple leads, suggestive of

    STEMI in 2 cases, and NSTE MI in 3 cases, raised cardiac enzymes,STEMI in 2 cases, and NSTE MI in 3 cases, raised cardiac enzymes,

    severe LV dysfunction, and normal coronariessevere LV dysfunction, and normal coronaries

    IABP support was required in 3 cases.IABP support was required in 3 cases.

    All the patients made a complete recovery, and are asymptomatic atAll the patients made a complete recovery, and are asymptomatic at

    11--month to 6month to 6--year followyear follow--up.up.

  • 8/4/2019 Apical Ballooning Syndrome

    29/33

    Unanswered QuestionsUnanswered Questions

    Why do middleWhy do middle--aged/elderly women appearaged/elderly women appearsusceptible to this disorder?susceptible to this disorder?

    Exactly how does psychological stress trigger itsExactly how does psychological stress trigger itssudden onset?sudden onset?

    Why is the LV apex selectively vulnerable to regionalWhy is the LV apex selectively vulnerable to regionalballooning?ballooning?

    Is this really a new disease with increasing incidence,Is this really a new disease with increasing incidence,or has it previously been unrecognized?or has it previously been unrecognized?

    Should pharmacological therapy be continuedShould pharmacological therapy be continued

    indefinitely?indefinitely?

  • 8/4/2019 Apical Ballooning Syndrome

    30/33

    Clinical RelevanceClinical Relevance

    Although rare, TLVABS must be considered as a d/d ofAlthough rare, TLVABS must be considered as a d/d ofACS or STEMIACS or STEMI

    Especially when extent of ECG abnormaliries exceedEspecially when extent of ECG abnormaliries exceedbiomarker evidence for myocardial necrosis and CAGbiomarker evidence for myocardial necrosis and CAG

    confirms noncritical CAD.confirms noncritical CAD.

    Prompt recognition and aggressive t/tPrompt recognition and aggressive t/t(pharmacological / mechanical)(pharmacological / mechanical)

  • 8/4/2019 Apical Ballooning Syndrome

    31/33

    THANKTHANK YOUYOU

  • 8/4/2019 Apical Ballooning Syndrome

    32/33

    ST-Segment Elevation in Various Conditions

    ConditionCondition FeatureFeature

    Normal (male pattern)Normal (male pattern) 90 percent of healthy young men

    Concave, 13mm, most marked in V2

    Early repolarizationEarly repolarization Most marked in V4, notching at J point

    Tall, upright T waves

    Reciprocal ST depression in aVR

    ST elevation normal variantST elevation normal variant V3- V5, inverted T waves

    Short QT, high QRS voltage

    LVHLVH Concave, Other features of LVH

    LBBBLBBB Concave

    ST deviation discordant from the QRS

    Acute PericarditisAcute Pericarditis Diffuse ST elevation, Reciprocal STdepression in aVR, Elevation

    seldom>5mm, PR-segment depression

  • 8/4/2019 Apical Ballooning Syndrome

    33/33

    ConditionCondition FeatureFeature

    HyperkalemiaHyperkalemia Other features of hyperkalemia presentOther features of hyperkalemia present

    Brugada SyndromeBrugada Syndrome rSR' in V1-2, ST- elevation in V1-2,

    typically downsloping

    Pulmonary embolismPulmonary embolism Changes simulating MI in both inferior

    and anteroseptal leads

    CardioversionCardioversion ST elevation, often >10 mm, lasting

    only a minute or two immediately after

    DC shock

    Prinzmetal AnginaPrinzmetal Angina Same as ST-segment elevation in

    infarction, but transient